Not a member? Get started building and deploying M2M applications, evaluating the Axeda Platform, and accessing a growing library of technical content and resources. Join today.
Beckman Coulter, Inc. (NYSE: BEC) is a $2.44 billion (U.S.) global biomedical company that develops and markets instruments, chemistries, software and supplies that simplify and automate laboratory processes throughout the biomedical continuum.
Axeda software enables Beckman Coulter to remotely monitor, diagnose and anticipate problems with its SYNCHRON LX-20® line of chemistry analyzers and COULTER LH 700 line of hematology analyzers deployed at hospitals across the United States.
Results:
Latest News
|
"Beckman Coulter is rated the leading hematology service provider by hospital laboratories, and now our service program is even better. The Axeda system increases our abilities to monitor events and troubleshoot potential problems. Customers enrolled in our PROService program will benefit from improved instrument uptime and performance, while Beckman Coulter will benefit from access to critical performance information in real-time, which enables us to lower our costs by reducing the number of unscheduled service visits." - Denny Kershner, Director of Marketing, Beckman Coulter |
"This technology is almost like a home security system: You set your alarm and then go to bed. It's a level of security that has enormous practical benefits to healthcare since instrument problems can be addressed before they result in instrument downtime. We have been able to increase instrument uptime and reduce service calls because the technology can identify potential problems before they result in a malfunction...often before my staff is even aware of the potential problem."
- James D. Peele, Ph.D., Director of Clinical Chemistry, Baptist Medical Center, Beckman Coulter customer
